VM:CC - Voyageur Pharmaceuticals Files Audited Annual Financial Statements and Grants Stock Options

(TheNewswire)

Calgary, Alberta, Canada / TheNewswire / March 26, 2024 - Voyageur PharmaceuticalsLtd . ( TSX.V: VM ) (USA: VYYRF) (" Voyageur " or the" Company "), announces that it has filed its annual auditedfinancial statements and management's discussion and analysis for theyear ended November 30, 2023 on SEDAR+.

Option Grant

Voyageur also announces that it has granted 3,700,000stock options (the " Options ") to directors, officers andconsultants of the Company pursuant to its incentive stock optionplan. On March 26, 2024, the Board approved the grant of Options, tobe effective on March 26, 2024, with an exercise price equal to thatof the closing price on that day of $0.07 cents per share. The Optionswere issued with 3,400,000 options vesting 12 months from the date ofissue and having a 5-year term, and the remaining 300,000 optionsvesting immediately and having a 10-year term.  The Options aresubject to regulatory and TSX Venture Exchange approval.

About Voyageur PharmaceuticalsLtd.

Voyageur, a Canadian public company trading under thesymbol VM on the TSX Venture Exchange, is in development of barium,iodine and carbon Active Pharmaceutical Ingredients (API) andhigh-performance, cost-effective imaging contrast agents. With astrategic focus on vertically integrating the barium, iodine and carbon contrast imaging market, Voyageur aims tobecome a key player by producing its own barium, iodine, and fullereneminerals.

Voyageur's business plan is set to generate cash flowby partnering with established third party GMP pharmaceutical manufacturers in Canada, ensuring the validation of its products by regulatory agenciesworldwide. Voyageur is forming partnerships with distributioncompanies in Canada and globally, who will sell Voyageur's products totheir existing markets. As the Company solidifies its presence in themarket, it plans to transition into a high-margin domesticmanufacturer of radiology drugs, utilizing the Frances Creek bariumsulfate to further expand its revenue streams at higher profitmargins. Voyageur is committed to sustainability and environmentalstewardship. The Company envisions a future where carbon neutrality isthe norm, and to achieve this, it plans to build state-of-the-artcarbon-neutral infrastructure. By investing in carbon neutral energysources and sustainable manufacturing practices, it aims to become 100% carbon neutral across all itsmanufacturing activities. Voyageur's commitment to the environment sets it apart as a pioneer inthe industry.

At the core of the Company's operations, Voyageur ownsa 100% interest in a barium sulphate (barite) project, the Frances Creek property. Additionally, Voyageur holds interests in a high-grade iodine,lithium, and bromine brine project situated in Utah, USA, furtherbolstering its position in the industry. Voyageur also owns a 100%interest in two battery mineral projects which focus on copper/zincdevelopment.

Voyageur's ambitious vision is to become the firstvertically integrated, carbon-neutral company in the imaging contrastmedia drug market. By controlling all primary input costs, from the sourcing of raw materials to final production, it plans to ensure unmatched quality and cost efficiency. Voyageur embodies the motto of" From the Earth to theBottle ," highlighting its commitment toresponsible sourcing and manufacturing practices.

For Further Information:

Neither the TSX Venture Exchange norits Regulation Services Provider (as that term is defined in thepolicies of the TSX Venture Exchange) accepts responsibility for theadequacy or accuracy of this news release.

Cautionary Statement Regarding “Forward-Looking”Information

This news release may contain certainforward-looking information and statements, including withoutlimitation, statements pertaining to regulatory and TSXV approval ofthe Options, and Voyageur's plans to become self sufficient andvertically integrated, and other statements herein, which expressly orimpliedly speak to Voyageur's expectations for its business andoperations. All statements included herein, other than statements ofhistorical fact, are forward-looking information and such informationinvolves various risks and uncertainties, including, withoutlimitation, global market factors and supply chain issues, risksrelating to the regulation and approval of Voyageur's products, andgeneral risks relating to Voyageur's business. There can be noassurance that such information will prove to be accurate, and actualresults and future events could differ materially from thoseanticipated in such information. A description of assumptions used todevelop such forward-looking information and a description of riskfactors that may cause actual results to differ materially fromforward-looking information can be found in the Company's disclosuredocuments on the SEDAR+ website at www.sedarplus.ca. Voyageur does notundertake to update any forward-looking information except inaccordance with applicable securities laws.

Copyright (c) 2024 TheNewswire - All rights reserved.